University of Melbourne

Established in 1853, the University of Melbourne is a public-spirited institution that makes distinctive contributions to society in research, learning and teaching and engagement. It’s consistently ranked among the leading universities in the world, with international rankings of world universities placing it as number 1 in Australia and number 33 in the world (Times Higher Education World University Rankings 2014-2015).

Geoffrey Donnan

Director FNI

15 past transactions

Synchron

Series C in 2022
Synchron develops an implantable medical device known as a stentrode, which is designed to establish a brain-computer interface. This minimally invasive device is delivered to the brain via a catheter and features electrode arrays that interpret neuronal signals. By modulating neural activity in targeted areas, the stentrode enables patients with motor impairments to regain control over digital devices, prosthetics, and other assistive technologies using their thoughts. Synchron's innovative approach aims to enhance the quality of life for individuals with significant mobility challenges.

Tiny Bright Things

Seed Round in 2022
Tiny Bright Things is a Melbourne-based company founded in 2020 by Ray Dagastine and Chris Bolton, specializing in innovative microscopy technology known as Halo microscopy. This technology significantly enhances the imaging and measurement of small or transparent objects, catering to the needs of industrial manufacturers and researchers across various fields. In particular, it serves sectors such as agrichemicals and pharmaceuticals, where the size and shape of powders are crucial. Additionally, the technology is instrumental in nanotechnology and life sciences, enabling accurate analysis of samples that are often tiny or transparent. By allowing imaging and measurement down to the scale of viruses, drug particles, and nanotubes without altering the samples, Tiny Bright Things supports effective research and development at various stages of discovery.

AIBUILD

Seed Round in 2021
Proudly partnered with The University of Melbourne and the Australian Research Council, AIBUILD is a big data and innovative solutions provider founded in 2017 as an emerging Australian startup. AIBUILD positions itself as a professional industry innovative solutions provider. Over the last three years in Australia, we have developed big data and software solutions for clients in industries ranging from the real estate industry to education and research, including: JH Market - Multi-warehouse solutions + distributed system for large industrial electrical products supplier (JinHang Lighting & Electrical) MyMart – Innovative e-commerce + smart supply chain solution for large Asian groceries (KT Mart) HousePro – Innovative real-time VR+AI matching system in global real-estate industry Crowdfunding platform - ARC IH150100006 (The University of Melbourne, Monash University, Australian Research Council) Otaro - Real-time online panorama/VR teaching platform (The University of Melbourne) A smart wind-driven natural ventilation system for buildings (The University of Melbourne, RMIT) We aim to ensure the widespread use of Artificial Intelligence Technology in Australia by helping our enterprise clients reduce costs and Improve consistency in their processes with Artificial Intelligence (AI) and virtual reality (VR) technology. We remain firmly committed to providing unparalleled quality design and impeccable service to ensure we meet the ranging needs of all our customers.

Synchron

Series B in 2021
Synchron develops an implantable medical device known as a stentrode, which is designed to establish a brain-computer interface. This minimally invasive device is delivered to the brain via a catheter and features electrode arrays that interpret neuronal signals. By modulating neural activity in targeted areas, the stentrode enables patients with motor impairments to regain control over digital devices, prosthetics, and other assistive technologies using their thoughts. Synchron's innovative approach aims to enhance the quality of life for individuals with significant mobility challenges.

AIBUILD

Pre Seed Round in 2020
Proudly partnered with The University of Melbourne and the Australian Research Council, AIBUILD is a big data and innovative solutions provider founded in 2017 as an emerging Australian startup. AIBUILD positions itself as a professional industry innovative solutions provider. Over the last three years in Australia, we have developed big data and software solutions for clients in industries ranging from the real estate industry to education and research, including: JH Market - Multi-warehouse solutions + distributed system for large industrial electrical products supplier (JinHang Lighting & Electrical) MyMart – Innovative e-commerce + smart supply chain solution for large Asian groceries (KT Mart) HousePro – Innovative real-time VR+AI matching system in global real-estate industry Crowdfunding platform - ARC IH150100006 (The University of Melbourne, Monash University, Australian Research Council) Otaro - Real-time online panorama/VR teaching platform (The University of Melbourne) A smart wind-driven natural ventilation system for buildings (The University of Melbourne, RMIT) We aim to ensure the widespread use of Artificial Intelligence Technology in Australia by helping our enterprise clients reduce costs and Improve consistency in their processes with Artificial Intelligence (AI) and virtual reality (VR) technology. We remain firmly committed to providing unparalleled quality design and impeccable service to ensure we meet the ranging needs of all our customers.

Apromore

Series A in 2020
Apromore is a platform that specializes in process mining solutions aimed at enhancing operational efficiency and effectiveness for organizations. By utilizing data from various enterprise systems, Apromore allows business teams to visualize, analyze, and improve their existing processes. The platform combines process mining capabilities with an intuitive design and extensive data connectivity, facilitating the identification of inefficiencies, friction points, and compliance violations. This enables organizations to leverage advanced data science techniques in a no-code environment, promoting digital transparency and operational excellence. With a focus on delivering actionable insights, Apromore supports teams in making informed decisions that lead to improved customer experiences and better risk management.

Denteric

Series A in 2019
Denteric is focused on developing vaccines to combat periodontal diseases, leveraging research from the University of Melbourne and collaboration with CSL Limited. The company's biotechnology platform targets the virulence factors produced by the bacterium Porphyromonas gingivalis and related species, which are known to cause various dental diseases and their complications. By creating these vaccines, Denteric aims to provide effective treatments for patients suffering from dental issues, improving their overall oral health. The company has secured funding that is distributed in three parts annually from 2019 to 2021, supporting its ongoing research and development efforts.

Tiny Bright Things

Pre Seed Round in 2019
Tiny Bright Things is a Melbourne-based company founded in 2020 by Ray Dagastine and Chris Bolton, specializing in innovative microscopy technology known as Halo microscopy. This technology significantly enhances the imaging and measurement of small or transparent objects, catering to the needs of industrial manufacturers and researchers across various fields. In particular, it serves sectors such as agrichemicals and pharmaceuticals, where the size and shape of powders are crucial. Additionally, the technology is instrumental in nanotechnology and life sciences, enabling accurate analysis of samples that are often tiny or transparent. By allowing imaging and measurement down to the scale of viruses, drug particles, and nanotubes without altering the samples, Tiny Bright Things supports effective research and development at various stages of discovery.

Clarity Pharmaceuticals

Venture Round in 2016
Clarity Pharmaceuticals is a clinical-stage company specializing in personalized medicine through innovative radiopharmaceutical technology. The company focuses on developing next-generation theranostic products that combine therapy and imaging, utilizing its proprietary SAR Technology. This platform is particularly effective with copper isotopes, enhancing the imaging and therapeutic capabilities of radiopharmaceuticals while addressing existing manufacturing and logistical challenges in oncology. Clarity's approach enables the radiolabeling of antibodies, which can be visualized using PET imaging. The resulting human imaging data helps determine whether a drug successfully targets a disease in individual patients, allowing for a tailored treatment strategy that optimizes patient outcomes by treating only those likely to respond to therapy.

Hatchtech

Venture Round in 2013
Hatchtech is an Australian company focused on developing innovative pest control solutions through its proprietary technology platform. The company's patented approach targets the egg hatch of pest species, effectively disrupting their lifecycle with a novel mode of action. Hatchtech's technology is designed to address various invertebrate pests, including ectoparasites such as head lice, as well as pests affecting animals, crops, and the built environment. Their flagship product offers a single-dose treatment that eliminates both head lice and their eggs in one application, providing an effective solution for infestations.

Omny Studio

Grant in 2012
Omny Studio is an all-in-one on-demand audio management solution that helps content creators grow their audience, reduce production costs and monetize. Our software-as-a-service enables radio stations and podcasters to focus on publishing high-quality content for listeners.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.